Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Biotechnology  20, 908 - 913 (2002)
Published online: 5 August 2002; | doi:10.1038/nbt725

Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching"

Casim A. Sarkar1, 2, Ky Lowenhaupt3, Thomas Horan6, Thomas C. Boone6, Bruce Tidor4, 5 & Douglas A. Lauffenburger1, 2, 3, 4

1  Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139-4307.

2  Biotechnology Process Engineering Center, Massachusetts Institute of Technology, Cambridge, MA 02139-4307.

3  Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139-4307.

4  Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, MA 02139-4307.

5  Department of Electrical Engineering & Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139-4307.

6  Department of Process Science, Amgen, Inc., Amgen Center, Thousand Oaks, CA 91320-1789.

Correspondence should be addressed to Douglas A. Lauffenburger lauffen@mit.edu or Bruce Tidor tidor@mit.edu
We describe a method for the rational design of more effective therapeutic proteins using amino acid substitutions that reduce receptor binding affinity in intracellular endosomal compartments, thereby leading to increased recycling in the ligand-sorting process and consequently resulting in longer half-life in extracellular medium. We demonstrate this approach for granulocyte colony-stimulating factor by using computationally predicted histidine substitutions that switch protonation states between cell-surface and endosomal pH. Molecular modeling of binding electrostatics indicates two different single-histidine mutants that fulfill our design requirements; experimental assays demonstrate that each mutant indeed exhibits an order-of-magnitude increase in medium half-life along with enhanced potency due to increased endocytic recycling.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Reduce, reuse, and recycle
Nature Biotechnology Research News (01 Sep 2002)

RESEARCH
Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes
Nature Cell Biology Brief Communication (01 May 2002)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
See also: Research News by Robinson
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy